Xeris Biopharma Holdings Inc (XERS)
Working Capital Ratio
20.68%
Quarterly · Period ending:
XERS Working Capital Ratio
Latest reported20.68%period ending
Latest reported20.68%period ending
XERS Quarterly Working Capital Ratio (87.10% → 20.68%)
Quarterly working capital ratio
High-resolution chart · PNG
XERS working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 20.6817% | |
| 33.9501% | |
| 34.0886% | |
| 29.1247% | |
| 27.0125% | |
| 21.6901% | |
| 20.807% | |
| 22.356% | |
| 28.5929% | |
| 29.7657% | |
| 18.9308% | |
| 21.6643% | |
| 23.1351% | |
| 26.1669% | |
| 32.8562% | |
| 26.5203% | |
| 30.3378% | |
| 32.8941% | |
| 20.8818% | |
| 66.3431% | |
| 72.0309% | |
| 79.4586% | |
| 77.9166% | |
| 79.9356% | |
| 80.5597% | |
| 71.8174% | |
| 55.1855% | |
| 68.84% | |
| 78.5256% | |
| 86.997% | |
| 89.7516% | |
| 92.6383% | |
| 92.4683% | |
| 82.2624% | |
| 87.0994% |